Article Details
Retrieved on: 2018-09-15 04:48:45
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
<div><b>Renaissance Technologies</b> LLC lessened its stake in shares of Valeant Pharmaceuticals (NYSE:VRX) (TSE:VRX) by 17.7% in the second quarter, ...</div>
Article found on:
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here